These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 10585342

  • 1. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: A new basis for gestational Down syndrome screening.
    Cole LA, Shahabi S, Oz UA, Bahado-Singh RO, Mahoney MJ.
    Clin Chem; 1999 Dec; 45(12):2109-19. PubMed ID: 10585342
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome.
    Bahado-Singh R, Oz U, Rinne K, Hunter D, Cole L, Mahoney MJ, Baumgarten A.
    Am J Obstet Gynecol; 1999 Oct; 181(4):929-33. PubMed ID: 10521756
    [Abstract] [Full Text] [Related]

  • 7. Maternal serum invasive trophoblast antigen (hyperglycosylated hCG) as a screening marker for Down syndrome during the second trimester.
    Palomaki GE, Neveux LM, Knight GJ, Haddow JE, Pandian R.
    Clin Chem; 2004 Oct; 50(10):1804-8. PubMed ID: 15319323
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The comprehensive midtrimester test: high-sensitivity Down syndrome test.
    Bahado-Singh R, Shahabi S, Karaca M, Mahoney MJ, Cole L, Oz UA.
    Am J Obstet Gynecol; 2002 Apr; 186(4):803-8. PubMed ID: 11967511
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hyperglycosylated hCG, a potential alternative to hCG in Down syndrome screening.
    Cole LA, Omrani A, Cermik D, Singh RO, Mahoney MJ.
    Prenat Diagn; 1998 Sep; 18(9):926-33. PubMed ID: 9793975
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hyperglycosylated-hCG (h-hCG) and Down syndrome screening in the first and second trimesters of pregnancy.
    Palomaki GE, Neveux LM, Haddow JE, Wyatt P.
    Prenat Diagn; 2007 Sep; 27(9):808-13. PubMed ID: 17590886
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA, Peterson CJ, French CA, Saller DN, Arvan DA.
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Screening of maternal serum for fetal Down's syndrome in the first trimester.
    Haddow JE, Palomaki GE, Knight GJ, Williams J, Miller WA, Johnson A.
    N Engl J Med; 1998 Apr 02; 338(14):955-61. PubMed ID: 9521983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.